Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma
Clinical trial NCT02116959 · TERMINATED
Trial details
- NCT number
- NCT02116959
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-23
- Primary completion
- 2019-05-25
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.